Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Randomized, Controlled Pilot Study of Niacinamide in Polycystic Kidney Disease
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
This PHASE2 trial investigates Polycystic Kidney Disease and is currently completed. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Mar 2019 — Jan 2021 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting PHASE2
▶ Show 4 earlier versions
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2018 — May 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Feb 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Kansas Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .